Notably, the antiseizure medication primidone, a TRPM3 antagonist, reduced the basal hyperactivity of mutant channels, providing a potential therapeutic approach for managing DEE-related symptoms [154]. Here, TRPM3 is linked to developmental and epileptic encephalopathy.